SOUTH SAN FRANCISCO, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company, announces that Chris ...